Informations sur le produit
CTLA-4 is a protein that regulates the immune response. The CTLA-4 - inhibitor (CTLA-4I) binds to CTLA-4 and blocks its interaction with immune cells, leading to an increase in the number of T cells. This drug has been shown to be effective against urothelial carcinoma and autoimmune diseases. It also has been used in some cases of angiosarcoma, toxic epidermal necrolysis, renal cell cancer, and other cancers. CTLA-4I is most often used in combination with platinum-based chemotherapy or radiation therapy. There are multicenter phase II clinical trials underway for this drug for use as a treatment for hematopoietic malignancies such as leukemia and lymphoma.
Propriétés chimiques
Question d’ordre technique sur : 3D-FC137667 CTLA-4 - inhibitor
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages